The case takes aim at the major pharmacy benefit managers, agency officials said, claiming that they favored more expensive insulin products and forced patients to pay more.
Related Posts
Cancer Diagnosis Like King Charles’s Is Not Unheard-Of
A patient checks into the hospital for a routine procedure to treat an enlarged prostate. And, unexpectedly, a test done…
New Havana Syndrome Studies Find No Evidence of Brain Injuries
New studies by the National Institutes of Health failed to find evidence of brain injury in scans or blood markers…
More Adolescent Boys Have Eating Disorders. Two Experts Discuss Why.
The medical and scientific understanding of eating disorders is changing and expanding. What happened? Dr. Smith: Historically, eating disorders have…